Hyris is proud to introduce its new brand identity and communication system, a further step to better sustain its commitment towards customers, partners, investors. The new Hyris Brand marks an important milestone in the Company evolution journey, which will continue at the forefront of biotech innovation and industry disruption.

As the new mutations of SARS-CoV-2 keep spreading world-wide, significant concerns increasingly worry both citizenship and the institutions. Even if some of these variants are innocuous, others may give the virus a selective advantage. Based on a risk assessment by major authorities involved in the fight against the spread of COVID-19, such as WHO, ECDC, CDC, these mutations are identified as Variants of Concern and monitored, alerting even more globally scientific and medical communities.

As the new mutations of SARS-CoV-2 keep spreading world-wide, significant concerns increasingly worry both citizenship and the institutions. Even if some of these variants are innocuous, others may give the virus a selective advantage. Based on a risk assessment by major authorities involved in the fight against the spread of COVID-19, such as WHO, ECDC, CDC, these mutations are identified as Variants of Concern and monitored, alerting even more globally scientific and medical communities.

We are excited to announce that Lallemand Health Solutions, a leading world-class probiotic manufacturer, chose the Hyris System™ for their internal certification protocol to produce and supply the best probiotic strains and products.

Hyris CE-IVD marked test for COVID human diagnostic "bKIT Virus Finder COVID-19" is at the core of the signature Article "Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection", from the Department of Laboratory Medicine of the National Institute for The Study and Treatment of Cancer IRCCS "Fondazione G Pascale" (IRCCS Pascale), of Naples (Italy)

Hyris bKIT Virus Finder Covid-19 is the first commercially available, rapid COVID-19 medical device approved by Health Canada for point-of-care human testing. Exclusively distributed by Songbird Life Science, it is fast becoming the preferred choice of industry leaders across Canada.

Hyris bCUBE based test kit is the only authorised medical device approved for human tests in Point of Care currently commercially available in Canada. Hyris Ltd. now focuses on supporting Canada in fully facing the new virus escalation.

Hyris Ltd first ranking for the Regione Lombardia COVID-19 Research fund with the project: COVES – Sviluppo e validazione di una metodica rapida per la rilevazione di SARS-CoV-2 su superfici ambientali

“Surveillance of mosquito infection status is critical for planning and deployment of proper mosquito control initiatives. Concurrently, Wolbachia is being widely used as a control method for arboviral transmission. Point-of-care (POC) detection assays are necessary for monitoring the infection prevalence and geographic range of viruses as well as Wolbachia in mosquito vector populations.“

We are proud of our last result, a publication on Immunological Reviews of the paper “Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment”.

Hyris Trade Fairs Analytica, March 31^st to April 3^rd 2020, Messe München

A species-specific hydrolysis probe assay was developed, validated, and evaluated for the performance of the assay in accurately identifying the species of interest using the following analytical validation criteria:

Hyris introduces probiotic bKITs, fully working with our bCUBE device.

Check our catalog HERE and do not forget to subscribe to our mailing list to be up to date with our products (see bottom).

PCR methods are the most commonly used DNA-based identity tool in the commercial food, beverage, and natural health product markets.

These methods are routinely used to identify foodborne pathogens and allergens in food. Proper validation methods for some sectors have been established, while they are still in development in other markets, such as botanicals. A survey of the literature indicates that some validation criteria are not addressed when developing PCR tests for botanicals.

We provide recommendations for qualitative real-time PCR methods for validating identity tests for botanical ingredients.

University of Guelph

Nature's Bounty

Herbalife

Hyris ltd

FULL ARTICLE LINK